CRST-1 is a cancer therapeutic effect created when combining Linebacker with leading anti-cancer drugs which inhibits PIM and increases the efficacy of the cancer treatment. This project was inspired by and named after Christy Bastian, a personal friend of Daryl Thompson who gave him the idea that you could fight cancer more effectively if you could “take away cancer’s ability to fight”


  • Licensing Status

    CRST-1 has been licensed to ProPhase Labs through Impact Biomedical.

Project Details

The CRST-1 effect is a combination of leading off-patent cancer drugs and Linebacker to increase the efficacy of both drugs to fight cancer.

  • 1
    17/530,956 Patent Application